While the recent CLEAR III trial using tissue-type plasminogen activator (alteplase) with an EVD to accelerate hematoma clearance in adult IVH patients with hydrocephalus showed an improvement in survival, it did not improve functional outcome [26]. The gene discussed is PLAT; the disease is Hydrocephalus.